CNAM
BEAT

Campbell Newman Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Campbell Newman Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,161
Closed -$1.09M – 128
2020
Q4 		$1.09M Buy
15,161
+1,115
+8% +$58.4K 0.12% 78
2020
Q3 		$640K Buy
14,046
+255
+2% +$10.7K 0.08% 89
2020
Q2 		$623K Buy
13,791
+123
+0.9% +$5.51K 0.09% 86
2020
Q1 		$526K Sell
13,668
-770
-5% -$35.4K 0.09% 80
2019
Q4 		$668K Buy
14,438
+97
+0.7% +$4.2K 0.09% 89
2019
Q3 		$584K Sell
14,341
-110
-0.8% -$4.75K 0.08% 99
2019
Q2 		$696K Buy
14,451
+952
+7% +$50K 0.1% 87
2019
Q1 		$845K Buy
13,499
+325
+2% +$22.3K 0.13% 71
2018
Q4 		$787K Buy
13,174
+1,372
+12% +$82.4K 0.14% 70
2018
Q3 		$761K Buy
11,802
+616
+6% +$34.4K 0.11% 78
2018
Q2 		$503K Buy
11,186
+504
+5% +$20.1K 0.08% 100
2018
Q1 		$332K Buy
10,682
+548
+5% +$18K 0.06% 115
2017
Q4 		$303K Buy
10,134
+1,796
+22% +$52K 0.05% 116
2017
Q3 		$275K Buy
+8,338
New +$289K 0.05% 114

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Campbell Newman Asset Management's BEAT Position: Q1 2021 in Review

Campbell Newman Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 15,161 shares — an estimated $1.09M sold.

Campbell Newman Asset Management first reported a position in BEAT in Q3 2017 and held it in 14 quarters. The position peaked at $1.09M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Campbell Newman Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Campbell Newman Asset Management sold 15,161 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.09M.
  • Campbell Newman Asset Management first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 14 quarters.
  • Campbell Newman Asset Management's BioTelemetry, Inc. position peaked at $1.09M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Campbell Newman Asset Management's 13F filing for Q1 2021, filed 19 Apr 2021.